MRI vs. CT: Choosing the Right Anatomical Imaging Modality
The global Preclinical Imaging market is projected to grow at a CAGR of 5.1% from 2024 to 2034, reaching USD 8.36 billion by 2034. In 2024, the market size is estimated at USD 4.19 billion.

Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations. 

The global Preclinical Imaging market is projected to grow at a compound annual growth rate (CAGR) of 5.1% between 2024 and 2034. By 2034, the market's revenue is expected to reach USD 8.36 billion, following a steady growth trajectory. In 2024, the market size is estimated to be valued at USD 4.19 billion. 

The global preclinical imaging market report highlights cutting-edge imaging technologies utilized in preclinical research to study diseases, facilitate drug development, and assess biological processes in animal models. These technologies play a vital role in translational research by bridging the gap between basic science and clinical applications. Preclinical imaging enables the in vivo visualization of molecular-level biological processes in animal models, providing valuable insights into human diseases. 

The global preclinical imaging market encompasses a key segment of the healthcare and biotechnology industry, focusing on the development, production, and application of imaging technologies and systems for preclinical research. This involves visualizing biological processes at the molecular, cellular, tissue, or whole-animal level, primarily in non-human subjects, to support advancements in drug discovery, development, and translational research. 

Market Scope 

Report Attributes 

Market Size in 2024: USD 4.19 Billion 

Market Forecast by 2034: USD 8.36 Billion 

CAGR % (2024-2034): 5.1% 

Base Year: 2023 

Historic Data: 2019-2023 

Forecast Period: 2024-2034 

Report USP: Production, Consumption, company share, company heatmap, company production capacity, growth factors, and more 

Segments Covered: By Product, By Modality, By Application, By End-Use, and By Region 

Regional Scope: North America, Europe, APAC, Latin America, and Middle East and Africa 

Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Benelux, Nordic Countries, Russia, China, India, Japan, South Korea, Australia, Indonesia, Thailand, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Egypt, South Africa, Nigeria 

Market Segments 

By Product: 

CT Imaging 

MRI Imaging 

PET/SPECT Imaging 

Multi-modal Imaging 

Optical Imaging 

Ultrasound Imaging 

Photoacoustic Imaging 

Reagents 

Others 

By Application: 

Drug Discovery and Development 

Disease Research 

Others 

By Modality: 

Standalone 

Integrated 

By End-Use: 

MRI vs. CT: Choosing the Right Anatomical Imaging Modality
disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations